Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Exercise in People With Systemic SclerosisCompleted
NCT05234671NAUpdated Oct 15, 2024
Sponsor: Sheffield Hallam University
Systemic Sclerosis
United Kingdom
Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory TargetRecruiting
NCT03850301NAUpdated Oct 15, 2024
Sponsor: Imperial College London
Multiple Sclerosis
United Kingdom
Propionic Acid in Multiple SclerosisCompleted
NCT06402487Phase 2, Phase 3Updated Oct 15, 2024
Sponsor: Salzburger Landeskliniken
Multiple Sclerosis
Austria
Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.Completed
NCT05811949N/AUpdated Oct 15, 2024
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo
Multiple Sclerosis
Italy
Functional Electrostimulation on the Upper Lip in Multiple SclerosisUnknown
NCT06638775NAUpdated Oct 15, 2024
Sponsor: Universidad de Burgos
Electrode Site Reaction · Therapy · Directly Observed Therapy
Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MSUnknown
NCT04874597N/AUpdated Oct 15, 2024
Sponsor: Dr Recai Turkoglu
Multiple Sclerosis
Turkey (Türkiye)
Investigating Visuo-spatial Abilities and Psychological Effects in West Nile and Multiple Sclerosis Patients with a Focus on a Possible Rehabilitation ProtocolRecruiting
NCT06640660NAUpdated Oct 15, 2024
Sponsor: IRCCS San Camillo, Venezia, Italy
Multiple Sclerosis · West Nile Virus
Italy
The Effect of the Human Care Model on Patients With Multiple SclerosisUnknown
NCT06634758NAUpdated Oct 10, 2024
Sponsor: Saglik Bilimleri Universitesi
Nursing Caries
Turkey (Türkiye)
Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.Terminated
NCT04877457Phase 4Updated Oct 9, 2024
Sponsor: Yale University
Radiologically Isolated Syndrome · Multiple Sclerosis
United States
PTNS for Female Patients Suffering From Multiple SclerosisTerminated
NCT05422625NAUpdated Oct 9, 2024
Sponsor: Corewell Health East
Multiple Sclerosis · Overactive Bladder
United States
A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With OfatumumabCompleted
NCT04667117Phase 4Updated Oct 9, 2024
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States
Deuterium Metabolic Imaging in People with Multiple SclerosisRecruiting
NCT06611280N/AUpdated Oct 9, 2024
Sponsor: University of Aarhus
Multiple Sclerosis (MS) - Relapsing-remitting
Denmark
Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic ClaudicationRecruiting
NCT04635436NAUpdated Oct 8, 2024
Sponsor: Istituto Auxologico Italiano
Multiple Sclerosis · Poststroke/CVA Hemiparesis · Parkinson Disease · Amputation
Italy
Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple SclerosisNot Yet Recruiting
NCT06627465N/AUpdated Oct 4, 2024
Sponsor: Amsterdam UMC, location VUmc
Multiple Sclerosis
Netherlands
Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization ExercisesCompleted
NCT05885282NAUpdated Oct 2, 2024
Sponsor: Hacettepe University
Multiple Sclerosis · Ataxia
Turkey (Türkiye)
A Systems Approach to Understanding Disease Processes in Multiple SclerosisCompleted
NCT05081700N/AUpdated Oct 2, 2024
Sponsor: Providence Health & Services
Multiple Sclerosis
United States
Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple SclerosisTerminated
NCT04819360Phase 4Updated Sep 27, 2024
Sponsor: Brigitte Schürch
Urinary Bladder, Neurogenic · Multiple Sclerosis
Switzerland
Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical)Completed
NCT05974839N/AUpdated Sep 26, 2024
Sponsor: State University of New York at Buffalo
Primary Progressive Multiple Sclerosis
United States
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS StudyCompleted
NCT04754542N/AUpdated Sep 25, 2024
Sponsor: University of Colorado, Denver
Multiple Sclerosis
United States
Pilates, Yoga and Tai Chi Exercises' Effect on Balance and Gait in Patients With Multiple SclerosisNot Yet Recruiting
NCT06612138NAUpdated Sep 25, 2024
Sponsor: Cairo University
Multiple Sclerosis
A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)Completed
NCT02714036Phase 1, Phase 2Updated Sep 24, 2024
Sponsor: MediciNova
Amyotrophic Lateral Sclerosis
United States
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)Recruiting
NCT06474520NAUpdated Sep 20, 2024
Sponsor: Tongji Hospital
Idiopathic Inflammatory Demyelinating Disease · Multiple Sclerosis · Neuromyelitis Optica Spectrum Disorder · Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
China
The Effect of Iyengar Yoga Practice on Patients with Multiple SclerosisCompleted
NCT05247372NAUpdated Sep 19, 2024
Sponsor: University Hospital, Motol
Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
Czechia
A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) ParticipantsTerminated
NCT05701423N/AUpdated Sep 19, 2024
Sponsor: Biogen
Multiple Sclerosis
Germany
Effect of Combined Exercise Training in Patients With Multiple SclerosisNot Yet Recruiting
NCT06595394NAUpdated Sep 19, 2024
Sponsor: Uskudar University
Multiple Sclerosis

Previous page Next page